Newer asthma therapies

Lewis J Smith*

*Corresponding author for this work

Research output: Contribution to journalShort survey

6 Citations (Scopus)

Abstract

In patients with asthma, the overall response rate to the gold standard treatment, corticosteroids, may be as low as 70%. Clearly, there is a need to identify treatments that are effective when corticosteroids are not. Malmstrom and colleagues' study in this issue contributes to other studies that have increased our understanding of the beneficial effects and safety of leukotriene receptor antagonists.

Original languageEnglish (US)
Pages (from-to)531-532
Number of pages2
JournalAnnals of Internal Medicine
Volume130
Issue number6
DOIs
StatePublished - Mar 16 1999

Fingerprint

Adrenal Cortex Hormones
Asthma
Leukotriene Antagonists
Safety
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Smith, Lewis J. / Newer asthma therapies. In: Annals of Internal Medicine. 1999 ; Vol. 130, No. 6. pp. 531-532.
@article{8bea3dcc0d48457096ea66e16b43534b,
title = "Newer asthma therapies",
abstract = "In patients with asthma, the overall response rate to the gold standard treatment, corticosteroids, may be as low as 70{\%}. Clearly, there is a need to identify treatments that are effective when corticosteroids are not. Malmstrom and colleagues' study in this issue contributes to other studies that have increased our understanding of the beneficial effects and safety of leukotriene receptor antagonists.",
author = "Smith, {Lewis J}",
year = "1999",
month = "3",
day = "16",
doi = "10.7326/0003-4819-130-6-199903160-00018",
language = "English (US)",
volume = "130",
pages = "531--532",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "6",

}

Newer asthma therapies. / Smith, Lewis J.

In: Annals of Internal Medicine, Vol. 130, No. 6, 16.03.1999, p. 531-532.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - Newer asthma therapies

AU - Smith, Lewis J

PY - 1999/3/16

Y1 - 1999/3/16

N2 - In patients with asthma, the overall response rate to the gold standard treatment, corticosteroids, may be as low as 70%. Clearly, there is a need to identify treatments that are effective when corticosteroids are not. Malmstrom and colleagues' study in this issue contributes to other studies that have increased our understanding of the beneficial effects and safety of leukotriene receptor antagonists.

AB - In patients with asthma, the overall response rate to the gold standard treatment, corticosteroids, may be as low as 70%. Clearly, there is a need to identify treatments that are effective when corticosteroids are not. Malmstrom and colleagues' study in this issue contributes to other studies that have increased our understanding of the beneficial effects and safety of leukotriene receptor antagonists.

UR - http://www.scopus.com/inward/record.url?scp=0033574196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033574196&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-130-6-199903160-00018

DO - 10.7326/0003-4819-130-6-199903160-00018

M3 - Short survey

VL - 130

SP - 531

EP - 532

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 6

ER -